BIO
NYSE
US
Bio-Rad Laboratories, Inc. Class A Common Stock
$293.21
▼ $-2.76
(-0.93%)
Vol 9K
Mkt Cap
$7.5B
P/E
9.9
ROE
10.9%
Margin
29.4%
Beta
1.13
52W
$211–$343
Wall Street Consensus
10 analysts · Apr 20262
Strong Buy
4
Buy
4
Hold
0
Sell
0
Strong Sell
60.0%
Buy Rating
Price Chart
Similar Stocks
TEM
Tempus AI Inc
$10.5B
RVTY
Revvity Inc
P/E 41.6
$10.0B
TEM
Tempus AI Inc
$10.5B
TECH
Bio-Techne Corp
P/E 119.2
$9.2B
CRL
Charles River Laboratories International Inc
$8.6B
RGEN
Repligen Corp
P/E 5307.1
$9.2B
BRKR
Bruker Corp
$7.2B
AVTR
Avantor Inc
$5.4B
SHC
Sotera Health Co
P/E 90.4
$5.0B
TXG
10X Genomics Inc
$2.1B
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $2.73 | $2.51 | $-0.22 |
| Sep 2025 | $1.95 | $2.26 | +$0.31 |
| Jun 2025 | $1.75 | $2.61 | +$0.86 |
| Mar 2025 | $1.83 | $2.54 | +$0.71 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $667.5M | $585.4M | $651.6M | $653.0M | $693.2M |
| Net Income | — | -$715.8M | $64.0M | $317.8M | -$341.9M | $720.0M |
Key Ratios
ROA (TTM)
7.6%
P/S (TTM)
2.92
P/B
1.1
EPS (TTM)
$27.91
CF/Share
$-0.16
Rev Growth 3Y
-2.7%
52W High
$343.12
52W Low
$211.43
$211.43
52-Week Range
$343.12
Financial Health
Free Cash Flow
$119.1M
Net Debt
$856.3M
Cash
$529.8M
Total Debt
$1.4B
As of Dec 31, 2025
How does BIO compare to Life Sciences Tools & Services peers?
Peer group: Peers · Life Sciences Tools & Services (Peers) · 10 companies
BIO valuation vs Life Sciences Tools & Services peers
P/E ratio
9.9
▼
83%
below
peers
(59.0)
vs Peers
vs Industry
Undervalued
P/S ratio
2.9
▼
5%
below
peers
(3.1)
vs Peers
vs Industry
Fair value
P/B ratio
1.1
▼
66%
below
peers
(3.3)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.4%)
vs Peers
vs Industry
Low yield
BIO profitability vs Life Sciences Tools & Services peers
ROE
10.9%
▲
600%
above
peers
(-2.2%)
vs Peers
vs Industry
Top tier
Net margin
29.4%
▲
776%
above
peers
(-4.4%)
vs Peers
vs Industry
Top tier
Gross margin
52.0%
▲
4%
above
peers
(49.8%)
vs Peers
vs Industry
In line
ROA
7.6%
▲
597%
above
peers
(-1.5%)
vs Peers
vs Industry
Top tier
BIO financial health vs Life Sciences Tools & Services peers
D/E ratio
—
▼
0%
below
peers
(64.5)
vs Peers
vs Industry
High debt
Current ratio
5.6
▲
110%
above
peers
(2.7)
vs Peers
vs Industry
Strong liquidity
Beta
1.1
▼
10%
below
peers
(1.3)
vs Peers
vs Industry
More volatile
BIO fundamentals radar
BIO
Peer median
Industry
BIO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BIO vs peers: key metrics
Latest News
Hezbollah Chief Torches 'Futile' Israel Talks, Urges Lebanon Walkout As Rubio Hypes …
ZeroHedge · Apr 15
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Biogen, Birkenstock, Fastly, …
Yahoo Finance · Apr 14
Why Biohaven Stock Crushed it on Monday
Nasdaq · Apr 14
Wedbush Bullish on Nuvation Bio (NUVB) As NUVB Expands Safusidenib Rights
Yahoo Finance · Apr 13
Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000
Nasdaq · Apr 12